Clinical Trials Directory

Trials / Completed

CompletedNCT01514292

Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System

PTL-900590 Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
DexCom, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness and safety of the Dexcom G4 System when used as an adjuvant to blood glucose testing over a 7-day period in people \>18 years-old with diabetes mellitus. The primary objective is to characterize the System performance with respect to laboratory reference venous sample measurements. The device performance will be primarily evaluated in terms of point and rate accuracy of the G4 System in reference to YSI. Safety of the G4 System will be characterized by Adverse Device Effects and Serious Adverse Device Effects experienced by study participants.

Detailed description

The primary objective is to characterize the System performance with respect to laboratory reference venous sample measurements. The device performance will be primarily evaluated in terms of point and rate accuracy of the G4 System in reference to YSI. The trend accuracy of the device performance, i.e., continuous glucose error grid analysis, will be evaluated as well as the temporal G4 System accuracy at different glucose rates of changes and different glucose ranges (hypoglycemic, euglycemic, and hyperglycemic ranges). The primary matched paired (Sensor-YSI) measurements will be collected during multiple in-clinic days.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous Glucose Monitoring of glucose levels (Dexcom)Manipulation of glucose levels during multiple clinic days. Achieved through diet, exercise and insulin regimen defined in protocol.Evaluation of CGM performance characteristics in reference to a laboratory standard.

Timeline

Start date
2011-12-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2012-01-23
Last updated
2015-10-05
Results posted
2015-10-05

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01514292. Inclusion in this directory is not an endorsement.